公开(公告)号：US20240017112A1

公开(公告)日：2024-01-18

申请号：US18297921

申请日：2023-04-10

申请人： Yinglin HAN

发明人： Qingyong SU

IPC分类号： A63B4/00

CPC分类号： A63B4/00 ,  A63B2210/50

摘要： The present disclosure may provide a balance beam. The balance beam may include a beam body and one or more support assemblies configured to support the beam body. The beam body may include one or more chambers. Each of the one or more chambers may be configured to accommodate at least a portion of one of the one or more support assemblies. Each of the one or more support assemblies may be connected with the beam body via a first connection. The support assembly may be configured to rotate, through the first connection, along a first rotation axis for moving into the one or more chambers.

公开(公告)号：US20090281324A1

公开(公告)日：2009-11-12

申请号：US12437636

申请日：2009-05-08

申请人： Datong Tang ,  Yinglin Han ,  Yanhe Huang ,  Ly Tam Phan ,  Yat Sun Or ,  Zhe Wang

发明人： Datong Tang ,  Yinglin Han ,  Yanhe Huang ,  Ly Tam Phan ,  Yat Sun Or ,  Zhe Wang

IPC分类号： C07D417/04

CPC分类号： C07D417/04

摘要： The present invention relates generally to novel methods for the synthesis of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

摘要翻译： 本发明一般涉及合成O- [5-（4-氨基 - 噻唑-2-基） - 吡啶-2-基甲基] - 羟胺的新方法，其是合成桥接的 红霉素衍生物及其各自的药学上可接受的盐在PCT申请WO 03/097659 A1中。 特别地，本发明涉及制备式（Ia）化合物的方法和中间体：

公开(公告)号：US07842813B2

公开(公告)日：2010-11-30

申请号：US12437636

申请日：2009-05-08

申请人： Datong Tang ,  Yinglin Han ,  Yanhe Huang ,  Ly Tam Phan ,  Yat Sun Or ,  Zhe Wang

发明人： Datong Tang ,  Yinglin Han ,  Yanhe Huang ,  Ly Tam Phan ,  Yat Sun Or ,  Zhe Wang

IPC分类号： C07D417/04

CPC分类号： C07D417/04

摘要： The present invention relates generally to novel methods for the synthesis of O-[5-(4-amino-thiazol-2-yl)-pyridin-2-ylmethyl]-hydroxylamine which is an essential reagent in the synthesis of one of the bridged erythromycin derivatives and their respective pharmaceutically acceptable salts in PCT Application WO 03/097659 A1. In particular, the present invention relates to processes and intermediates for the preparation of a compound of formula (Ia):

摘要翻译： 本发明一般涉及合成O- [5-（4-氨基 - 噻唑-2-基） - 吡啶-2-基甲基] - 羟胺的新方法，其是合成桥接的 红霉素衍生物及其各自的药学上可接受的盐在PCT申请WO 03/097659 A1中。 特别地，本发明涉及制备式（Ia）化合物的方法和中间体：

公开(公告)号：US20240269502A1

公开(公告)日：2024-08-15

申请号：US18167898

申请日：2023-02-13

申请人： Yinglin HAN

发明人： Qingyong SU

IPC分类号： A63B1/00

CPC分类号： A63B1/005 ,  A63B2210/50

摘要： The present disclosure provides a foldable horizontal bar. The foldable horizontal bar may include a horizontal bar; a pair of supports configured to support the horizontal bar; and a pair of bases. Each base may include a first movable part, a second movable part, and a fixed part. The fixed part may be mechanically connected with the first movable part and the second movable part. The first movable part may be rotatable around a first connection point between the fixed part and the first movable part within a preset angle. The second movable part may be rotatable around a second connection point between the fixed part and the second movable part within the preset angle. The preset angle being larger than 90 degrees.